Back to results
CompletedPhase 2

Safety of Diamyd® in Patients With LADA (Latent Autoimmune Diabetes in Adult)

NCT00456027

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Alingsås Hospital

Alingsås, Sweden

+16 additional locations

View on ClinicalTrials.gov
Safety of Diamyd® in Patients With LADA (Latent Autoimmune Diabetes in Adult) — TrialFind